Citation Tools

PDF

Original Article
Reduction of podocyte globotriaosylceramide content in adult male patients with Fabry disease with amenable GLA mutations following 6 months of migalastat treatment

Download to a citation manager

Cite this article as:
Mauer M, Sokolovskiy A, Barth JA, et al
Reduction of podocyte globotriaosylceramide content in adult male patients with Fabry disease with amenable GLA mutations following 6 months of migalastat treatment